Priority driven research
Overview
Cancer Australia administers a dedicated cancer research budget and has developed the Priority-driven Collaborative Cancer Research Scheme to support research that reduces the impact of cancer on the community and improves outcomes for people affected by cancer.
Cancer Australia has established this annual project grant scheme to partner with other organisations that fund cancer research to:
- better coordinate funding of priority-driven cancer research,
- fund research which can impact on practice and policy and improve outcomes,
- foster collaboration between cancer researchers to build Australia’s cancer research capacity, and
- foster consumer participation in cancer research, from design to implementation.
The National Health and Medical Research Council (NHMRC) facilitates registration and initial assessment of applications, and will endorse grants funded through this scheme.
Applications for 2010 Round grants (now open)
Cancer Australia and our funding partners – beyondblue, CanTeen, Cancer Council New South Wales, Cancer Council Tasmania, Cure Cancer Australia Foundation, Leukaemia Foundation, Meat and Livestock Australia, the National Centre for Gynaecological Cancers, the National Breast Cancer Foundation, the National Lung Cancer Program, and the Prostate Cancer Foundation of Australia – have invited applications for Priority-driven Collaborative Cancer Research Grants to commence in 2011.
Project grants are offered in the following categories:
Funding Category A: Project grants of up to three years duration, with funding available up to $600,000 (GST-exclusive), with a maximum in any one year of $200,000 (GST-exclusive) will be offered by Cancer Australia, beyondblue, Cancer Council New South Wales, Leukaemia Foundation, National Breast Cancer Foundation, National Lung Cancer Program and the Prostate Cancer Foundation Australia. All project grant applications ranging from 1 to 3 years within a budget ranging from $10,000 to $200,000 per annum will be considered by Cancer Australia and these funding partners;
Funding Category B: Project grants of up to three years duration, with funding available up to $200,000 (GST-exclusive), with a maximum in any one year of $66,666 (GST-exclusive) will be offered by Meat and Livestock Australia;
Funding Category C: Project grants of up to two years duration, with funding available up to $200,000 (GST-exclusive) per annum (total: $400,000 GST-exclusive) will be offered by the National Centre for Gynaecological Cancers;
Funding Category D: Project grants of up to five years duration, with funding available up to $750,000 (GST exclusive), with a maximum in any one year of $150,000 (GST-exclusive) will be offered by the partnership of beyondblue and CanTeen, to undertake longitudinal research with: young people (aged 12-24 years) with cancer; their siblings; and their parents/ primary carers, exploring psychosocial needs, psychological distress (depression /anxiety) and coping, across the cancer journey;
Funding Category E: Project grants of one year, with funding available up to $50,000 (GST-exclusive) will be offered by Cancer Council Tasmania. All project grant applications within a budget ranging from $10,000 to $50,000 will be considered.
Funding Category F: Project grants of one year duration up to $90,000 (GST-exclusive) will be offered by the Cure Cancer Australia Foundation to support post-doctoral researchers with less than seven years post-doctoral experience undertaking a one year research project into malignant disease. Cure Cancer Australia Foundation wishes to fund innovative, high-achieving, early-career researchers, and will be assessing the Track Record and Publications of the Chief Investigator submitted as part of the NHMRC application process to determine eligibility for these grants. This funding category cannot be used to provide a salary or other support for a young investigator as part of a larger PdCCRS project grant application.
Grant applications must relate to the research priority areas identified by Cancer Australia and/ or our funding partners.
2010 Round: Application documentation Contact: Dr Paul Jackson at Cancer Australia (paul.jackson@canceraustralia.gov.au)
Please note: The call for applications to the Priority-driven Collaborative Cancer Research Scheme for 2010 closes on 17 March 2010.
Research Priorities for Cancer Australia and funding partners for 2010 Round
Cancer Australia and its funding partners are pleased to announce their research priorities for the 2010 Round of the Priority-driven Collaborative Cancer Research Scheme (updated 18 Dec 2009) Research priorities for the 2010 round of the Priority-driven Collaborative Cancer Research Scheme were announced in early November to encourage discussion, collaboration, and planning between researchers prior to the call for applications. Applications for 2010 grants are now open.
Funding will be available for research that addresses the priorities of one or more of the following funding partners: - Cancer Australia
- Cancer Australia: National Centre For Gynaecological Cancers
- Cancer Australia: National Lung Cancer Program
- beyondblue: the national depression initiative
- Cancer Council New South Wales
- Cancer Council Tasmania
- CanTeen and beyondblue
- Cure Cancer Australia Foundation
- Leukaemia Foundation
- Meat & Livestock Australia
- National Breast Cancer Foundation
- Prostate Cancer Foundation of Australia
National Health and Medical Research Council and Cancer Australia – partners in cancer research: a joint statement by the National Health and Medical Research Council and Cancer Australia.
The Priority-driven Collaborative Cancer Research Scheme is an innovative research funding scheme which brings together government and other funders of cancer research to collaboratively fund cancer research in Australia. This research scheme is managed by Cancer Australia together with the NHMRC. The NHMRC and Cancer Australia have prepared a joint statement highlighting how research supported through the Priority-driven Collaborative Cancer Research Scheme complements cancer research activities funded by the NHMRC.
National Health and Medical Research Council and Cancer Australia – partners in cancer research: a joint statement by the National Health and Medical Research Council and Cancer Australia
Successful applicants for the 2009 Round of the Priority-driven Collaborative Cancer Research Scheme
Cancer Australia, beyondblue: the national depression initiative, Cancer Council Australia, Cure Cancer Australia Foundation, Leukaemia Foundation, National Centre for Gynaecological Cancers, National Breast Cancer Foundation, Prostate Cancer Foundation of Australia and Radiation Oncology Section of the Australian Government Department of Health and Ageing, are pleased to announce the successful applicants in the 2009 Round of the Priority-driven Collaborative Cancer Research Scheme
Successful applicants for 2008 Round of the Priority-driven Collaborative Cancer Research Scheme
Cancer Australia, beyondblue: the national depression initiative, Cancer Council Australia, the Cure Cancer Australia Foundation, and the National Breast Cancer Foundation, are pleased to announce the successful applicants in the 2008 round of the Priority-driven Collaborative Cancer Research Scheme.
Successful applicants for 2007 Round of the Priority-driven Collaborative Cancer Research Scheme
Cancer Australia, the National Breast Cancer Foundation, the Prostate Cancer Foundation of Australia, and Diagnostics and Technology Branch of the Australia Government Department of Health and Ageing are pleased to announce the successful applicants in the 2007 Round of the Priority-driven Collaborative Cancer Research Scheme.